Karunadu Oncology Haematology Associates Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 12-07-2024
- Paid Up Capital ₹ 4.30 Cr
as on 12-07-2024
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.00 Cr
as on 12-07-2024
- Revenue 6629876.00%
(FY 2020)
- Profit 72.06%
(FY 2020)
- Ebitda 199.37%
(FY 2020)
- Net Worth -23.93%
(FY 2020)
- Total Assets 2084.50%
(FY 2020)
About Karunadu Oncology Haematology Associates
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.30 Cr.
The company currently has active open charges totaling ₹10.00 Cr.
Pran Hanumanthu, Santosh Kulgod, Rajeev, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85320KA2018PTC119596
- Company No.
119596
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Dec 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Dharwad, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Karunadu Oncology Haematology Associates?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pran Hanumanthu  | Director | 01-Aug-2022 | Current |
| Santosh Kulgod | Director | 20-Jun-2020 | Current |
| Rajeev | Director | 26-Jun-2021 | Current |
| Jagadish Basavaraj | Director | 18-Dec-2018 | Current |
| Snehalreddy | Director | 18-Dec-2018 | Current |
| Lakshmi | Director | 26-Jun-2021 | Current |
Financial Performance and Corporate Structure Insights of Karunadu Oncology Haematology Associates.
Karunadu Oncology Haematology Associates Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 6629876% increase. The company also saw a substantial improvement in profitability, with a 72.06% increase in profit. The company's net worth observed a substantial decline by a decrease of 23.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Karunadu Oncology Haematology Associates?
In 2020, Karunadu Oncology Haematology Associates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Fourth Axis Diagnosis And Healthcare Cen Tre Llp
Active 6 years 11 monthsSantosh Kulgod is a mutual person
Fifth Axis Diagnosis And Healthcare Cent Re Llp
Active 6 years 6 monthsSantosh Kulgod is a mutual person
Seventh Axis Diagnosis And Healthcare Ce Ntre Llp
Active 4 years 3 monthsSantosh Kulgod is a mutual person
Eighth Axis Diagnosis And Healthcare Cen Tre Llp
Active 3 years 10 monthsSantosh Kulgod is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 27 Sep 2021 | ₹10.00 Cr | Open |
How Many Employees Work at Karunadu Oncology Haematology Associates?
Unlock and access historical data on people associated with Karunadu Oncology Haematology Associates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Karunadu Oncology Haematology Associates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Karunadu Oncology Haematology Associates's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
